Up next

Autoplay

Episode 40 - Breztri, Xywav, & Tecartus

1 Views • 08/29/25
Share
Side Effects
Side Effects
Subscribers
0

In today's episode we're going to talk first about the ongoing COPD triplet wars - with the most recent approval of Breztri for maintenance treatment of patients with chronic obstructive pulmonary disease. We'll also talk about the approval Xywav to treat cataplexy, Xeglyze for head lice, and we’ll also bring up approval of Tecartus, a new CAR-T therapy. Don't forget to like, share, and subscribe! Enjoy!


The Rx Daily Dose
Episode 40
August 3, 2020

★ Episode details: https://share.transistor.fm/s/fc6dc39b
★ Additional episodes: https://therxdailydose.transistor.fm

Show more
0 Comments sort Sort By

Up next

Autoplay